4 Largecap High Quarterly Margin and High ROE Stocks to Watch for Future Multibagger Potential: HAL, Nestle India, Torrent Pharma and Pidilite
- November 2, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
HAL Rs 4,853.70. Nestle India Rs 1,167. Torrent Pharma Rs 4,613.40. Pidilite Rs 1,461.60. Market caps from Rs 1.51 lakh crore to Rs 3.32 lakh crore. Data as of 30 Oct 2026.
Quick Answer
HAL, Nestle India, Torrent Pharma and Pidilite are the 4 picks in this high quarterly margin and high ROE stocks watchlist, with market caps between Rs 1.51 lakh crore and Rs 3.32 lakh crore. HAL stands out for the biggest five-year price gain at 607.71%, while Nestle India offers the highest return on equity at 67.85%. PE ratios run from 35.57 to 81.23, so compare each one with its industry PE before investing. All figures are as of 30 October 2026.
High quarterly margin and high ROE stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. HAL, Nestle India, Torrent Pharma and Pidilite meet that test, with market caps from Rs 1.51 lakh crore to Rs 3.32 lakh crore and HAL offering the biggest five-year price gain at 607.71%. Each of these companies has a latest quarter operating margin of at least 20 per cent and a return on equity of at least 20 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a latest quarter operating margin of at least 20 per cent and a return on equity of at least 20 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening high quarterly margin and high ROE stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 30 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are High Quarterly Margin and High ROE Stocks and Why Do They Attract Multibagger Interest?
High quarterly margin and high ROE stocks are shares of large companies that kept at least twenty paise of operating profit from every rupee of sales in the latest quarter and earn a return on equity of twenty per cent or more, a mix that marks a strong and efficient business. The four here cover aerospace, packaged food, pharmaceuticals and adhesives.
A high margin in the latest quarter shows current pricing power, and a high return on equity shows that shareholder money is used well, so the two together point to a business with a real edge. For high quarterly margin and high ROE stocks, both FY26 and the latest quarter showed growth. Whichever way you read high quarterly margin and high ROE stocks, the common thread is rising profit backed by complete financial data. For high quarterly margin and high ROE stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of high quarterly margin and high ROE stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for high quarterly margin and high ROE stocks before you decide.
High Quarterly Margin and High ROE Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 30 October 2026. HAL has the lowest PE of the group at 35.57, while Nestle India posts the highest return on equity at 67.85%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Hindustan Aeronautics | 4,853.70 | 3,31,595 | 35.57 | 48.59 | 22.21% | 0.00 | 3,479.10 to 5,149.90 |
| Nestle India | 1,167 | 2,61,771 | 68.70 | 34.68 | 67.85% | 0.09 | 1,159.40 to 1,553.00 |
| Torrent Pharmaceuticals | 4,613.40 | 1,75,124 | 81.23 | 36.42 | 25.49% | 1.79 | 3,480.60 to 5,250.00 |
| Pidilite Industries | 1,461.60 | 1,51,179 | 56.50 | 36.15 | 22.61% | 0.04 | 1,259.00 to 1,707.50 |
HAL: Return on Equity of 22.21%
Hindustan Aeronautics is India’s state-owned aerospace company that designs, makes and services fighter jets, helicopters, engines and avionics. It reported FY26 revenue of Rs 36,787.95 crore, up 9.68% year on year, and net profit of Rs 9,115.52 crore, up 8.98%. Net profit has compounded at 15.74% a year since FY22, while revenue has grown 9.48% a year. Operating margin was 40.89% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.
In the June 2026 quarter, revenue rose 15.26% to Rs 6,415.41 crore and net profit grew 14.88% to Rs 1,589.66 crore. The share price has gained 607.71% over five years. Domestic institutions raised their holding from 8.71% in September 2025 to 12.56% in September 2026. The stock trades at a PE of 35.57 against an industry PE of 48.59, below the sector average, with a return on equity of 22.21%.
Nestle India: Return on Equity of 67.85%
Nestle India makes Maggi, KitKat, Nescafe and other packaged foods and beverages. It reported FY26 revenue of Rs 23,194.95 crore, up 14.48% year on year, and net profit of Rs 3,499.08 crore, up 9.09%. Operating margin was 22.49% in FY26. The debt-to-equity ratio is 0.09, which keeps interest costs low.
The stock trades at a PE of 68.70 against an industry PE of 34.68, with a return on equity of 67.85%. In the September 2026 quarter, revenue rose 20.52% to Rs 6,808.60 crore and net profit grew 35.85% to Rs 1,009.61 crore. Foreign investors raised their holding from 9.82% in September 2025 to 11.69% in September 2026.
Torrent Pharma: 28.79% Profit CAGR Since FY22
Torrent Pharmaceuticals makes branded medicines for chronic therapies such as cardiac, gastro-intestinal and central nervous system care in India and overseas. It reported FY26 revenue of Rs 13,886.15 crore, up 20.34% year on year, and net profit of Rs 2,138.18 crore, up 11.87%. Net profit has compounded at 28.79% a year since FY22, while revenue has grown 12.38% a year. Operating margin was 22.70% in FY26.
In the June 2026 quarter, revenue rose 56.29% to Rs 4,909 crore and net profit grew 3.28% to Rs 566 crore. The share price has gained 194.63% over five years and 29.72% over the past year. Domestic institutions raised their holding from 9.28% in September 2025 to 12.87% in July 2026. The stock trades at a PE of 81.23 against an industry PE of 36.42, with a return on equity of 25.49%.
Pidilite: Return on Equity of 22.61%
Pidilite Industries makes Fevicol, Dr. Fixit and other adhesives and construction chemicals. It reported FY26 revenue of Rs 14,867.01 crore, up 11.05% year on year, and net profit of Rs 2,470.72 crore, up 17.87%. Net profit has compounded at 19.62% a year since FY22, while revenue has grown 10.54% a year. Operating margin was 25.81% in FY26. The debt-to-equity ratio is 0.04, which keeps interest costs low.
The stock trades at a PE of 56.50 against an industry PE of 36.15, with a return on equity of 22.61%. In the June 2026 quarter, revenue rose 20.96% to Rs 4,643.55 crore and net profit grew 30.29% to Rs 883.51 crore. Domestic institutions raised their holding from 9.15% in June 2025 to 9.88% in June 2026.
High Quarterly Margin and High ROE Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these high quarterly margin and high ROE stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | Latest Quarter Revenue Growth | Net Profit Growth (YoY) | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| HAL | 36,787.95 | 9,115.52 | 9.68% | 15.26% | 8.98% | 44.22% |
| Nestle India | 23,194.95 | 3,499.08 | 14.48% | 20.52% | 9.09% | 23.81% |
| Torrent Pharma | 13,886.15 | 2,138.18 | 20.34% | 56.29% | 11.87% | 33.73% |
| Pidilite | 14,867.01 | 2,470.72 | 11.05% | 20.96% | 17.87% | 28.62% |
Check the Univest Screener for live data on these high quarterly margin and high ROE stocks
Institutional Holding in HAL, Nestle India, Torrent Pharma and Pidilite
Institutional holding shows who is backing these high quarterly margin and high ROE stocks alongside the promoter. The table uses the latest reported quarter for each. Torrent Pharma has the deepest institutional backing, with FII and DII together holding 30.84% as of July 2026. Domestic institutions increased their holding over the past year in HAL (from 8.71% to 12.56%), Torrent Pharma (from 9.28% to 12.87%) and Pidilite (from 9.15% to 9.88%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| HAL | 71.64% | 9.42% | 12.56% | 6.38% | September 2026 |
| Nestle India | 62.76% | 11.69% | 10.67% | 14.87% | September 2026 |
| Torrent Pharma | 60.78% | 17.97% | 12.87% | 8.38% | July 2026 |
| Pidilite | 69.24% | 11.69% | 9.88% | 9.18% | June 2026 |
Risks to Weigh in High Quarterly Margin and High ROE Stocks
Being careful with high quarterly margin and high ROE stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Torrent Pharma trades at a PE of 81.23 against an industry PE of 36.42, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between High Quarterly Margin and High ROE Stocks
Picking from high quarterly margin and high ROE stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (34.68 to 48.59) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track HAL, Nestle India, Torrent Pharma and Pidilite live prices.
Conclusion
Among high quarterly margin and high ROE stocks, HAL stands out for the biggest five-year price gain at 607.71%, Nestle India for the highest return on equity at 67.85%, Torrent Pharma for the fastest profit growth, 28.79% a year since FY22 and Pidilite for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.04. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing high quarterly margin and high ROE stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on High Quarterly Margin and High ROE Stocks to Watch
Which are the best high quarterly margin and high ROE stocks to watch for multibagger potential?
Ans. HAL, Nestle India, Torrent Pharma and Pidilite are the 4 names this list highlights, with market caps of Rs 3,31,595 crore, Rs 2,61,771 crore, Rs 1,75,124 crore and Rs 1,51,179 crore respectively. HAL is notable for the biggest five-year price gain at 607.71%. Nestle India stands out for the highest return on equity at 67.85%. Torrent Pharma offers the fastest profit growth, 28.79% a year since FY22. Pidilite brings a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.04. These are watchlist names for high quarterly margin and high ROE stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Nestle India a good stock for long-term investors?
Ans. Nestle India has a return on equity of 67.85%, a PE of 68.70 against an industry PE of 34.68 and a market cap of Rs 2,61,771 crore. FY26 revenue rose 14.48%, and September 2026 quarter net profit grew 35.85%. Long-term returns in high quarterly margin and high ROE stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Torrent Pharma become a multibagger from here?
Ans. Torrent Pharma has already gained 194.63% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in high quarterly margin and high ROE stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 28.79% a year since FY22, and FY26 revenue rose 20.34%. At a PE of 81.23 against an industry PE of 36.42, valuation should be checked against that growth before investing.
What is the market cap of HAL, Nestle India, Torrent Pharma and Pidilite?
Ans. As of 30 October 2026, HAL has a market cap of Rs 3,31,595 crore, Nestle India has a market cap of Rs 2,61,771 crore, Torrent Pharma has a market cap of Rs 1,75,124 crore and Pidilite has a market cap of Rs 1,51,179 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on high quarterly margin and high ROE stocks.
What are the risks of investing in high quarterly margin and high ROE stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Torrent Pharma trades at a PE of 81.23 against an industry PE of 36.42, so earnings growth needs to hold up.
Why is Torrent Pharma trading at a PE of 81.23?
Ans. Torrent Pharma’s PE of 81.23 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 25.49%, profit growth of 28.79% a year since FY22 and FY26 revenue growth of 20.34%, which also means the stock is more sensitive if growth slows. Investors in high quarterly margin and high ROE stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in HAL, Nestle India, Torrent Pharma and Pidilite?
Ans. As of the latest reported quarter, FII and DII together hold 21.98% of HAL (9.42% and 12.56%), 22.36% of Nestle India (11.69% and 10.67%), 30.84% of Torrent Pharma (17.97% and 12.87%) and 21.57% of Pidilite (11.69% and 9.88%). Rising institutional holding is a useful signal in high quarterly margin and high ROE stocks, though it should be read with earnings trends rather than on its own.
